March 23, 2022
PAR-21-293 - Clinical and Translational Science Award (UM1 Clinical Trial Optional)
National Center for Advancing Translational Sciences (NCATS)
The purpose of this Notice is to inform potential applicants of the changes in the Eligibility for PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional).
Section III. Eligibility Information
Currently Reads:
1. Eligible Applicants
Eligible Organizations
The CTSA application may include domestic institutions of higher education, universities, medical research institutions / academic health centers, or non-profit research organizations other than institutions of higher education that conduct clinical and translational research; however, a graduate school accredited to award higher degrees related to clinical or translational science (e.g., M.S. or Ph.D. in topics such as Clinical Research, Public Health, Pharmacology, Nursing, Informatics, Health Economics, or Epidemiology) must be included (applicant or partnering institution). Partnerships are encouraged among various disciplines including medicine, dentistry, nursing, pharmacy, osteopathy, public health, engineering and others. Organizations with active grants funded under FOAs PAR-15-304, PAR-18-464 & PAR-18-940 that have more than 16 months of support remaining on the day of the submission deadline are not eligible to apply. NCATS encourages multiple institutions to participate in a single hub application, where this may further advance the goals of the program. A single contact institution would receive and administer the award.
Higher Education Institutions
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
Nonprofits Other Than Institutions of Higher Education
Local Governments
Federal Governments
Revised to Read:
1. Eligible Applicants
Eligible Organizations
The CTSA application may include domestic institutions of higher education, universities, medical research institutions / academic health centers, or non-profit research organizations other than institutions of higher education that conduct clinical and translational research; however, a graduate school accredited to award higher degrees related to clinical or translational science (e.g., M.S. or Ph.D. in topics such as Clinical Research, Public Health, Pharmacology, Nursing, Informatics, Health Economics, or Epidemiology) must be included (applicant or partnering institution). Partnerships are encouraged among various disciplines including medicine, dentistry, nursing, pharmacy, osteopathy, public health, engineering and others. Organizations with active grants funded under FOAs PAR-15-304, PAR-18-464 and PAR-18-940 that have more than 16 months of support remaining on the day of the submission deadline are not eligible to apply. NCATS encourages multiple institutions to participate in a single hub application, where this may further advance the goals of the program. A single contact institution would receive and administer the award.
Partner Institution(s) must be effectively integrated into the proposed activities of the CTSA UM1 hub and are necessary for attaining its strategic goals and research priorities. Therefore, a Partner Institution may be included as a partner in only one CTSA UM1 hub application. An organization named as a Partner Institution in a CTSA UM1 application or a CTSA UL1 award funded previously under PAR-18-940, PAR-18-464 or PAR-15-304 may not apply as an applicant organization to PAR-21-293 under the following scenarios:
CTSA UM1 applications from organizations named as a Partner Institution in a funded CTSA UM1 or CTSA UL1 award are not allowed, except under rare circumstances with compelling justification.
Higher Education Institutions
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
Nonprofits Other Than Institutions of Higher Education
Local Governments
Federal Governments
All other aspects of the Funding Opportunity Announcement remain unchanged.
Erica Rosemond, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-594-8927
Email: CTSAFOAQuestions@mail.nih.gov